Print

Purpose

The project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 90 Years
Eligible Genders
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

for RCT participant: 1. Age range 18 to 90 2. Self-identified African American male 3. Have had a stroke or TIA in the past 10 years based on date of hospital discharge from an acute stroke program or Emergency Room/physician visit for TIA 4. Barthel Index (BI) score of >= 40 5. Able to participate in group sessions Inclusion Criteria for Care Partner 1. Age range from 18 to 90 2. Able to participate in group sessions Inclusion criteria for peer educator: 1. Age range: from 18 to 90 2. Self-identified African American male 3. Have had a stroke or TIA 4. Able to participate in group sessions Inclusion Criteria for Peer Educator Care Partner 1. Age range: from 18 to 90 2. Able to participate in group sessions 3. Is either a family member, friend or other individual who is important in an enrolled peer educator's stroke recovery OR the family member, friend or other individual of someone who has had a stroke or TIA and is/was important in their stroke recovery

Exclusion Criteria

for RCT participant 1. Individuals who are unable or unwilling to provide written informed consent 2. Individuals who have had stroke due to sickle-cell disease Exclusion Criteria for Care Partner participant 1. Individuals who are unable or unwilling to provide written informed consent Exclusion Criteria for Peer Educator 1. Individuals who are unable or unwilling to provide written informed consent 2. Individuals who have had stroke due to sickle-cell disease Exclusion Criteria for Peer Educator's Care Partner 1. Individuals who are unable or unwilling to provide written informed consent

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Intervention Model Description
80 participants are assigned to receive TEAM, and 80 participants are assigned to wait list
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Intervention 		Participants randomized to TEAM intervention for 6 months, then observed for 6 month follow up
  • Behavioral: TargEted MAnageMent Intervention (TEAM)
    TEAM targets acquisition of self-management expertise and use of healthy behaviors that are intended to reduce stroke risk and burden. TEAM participants will continue in their regular medical care, supplemented by the TEAM intervention. Components are as follows: 1. A 60 minute initial session in which the nurse and the PED meet with the patient who has experienced stroke or TIA. The initial session will cover introductions, orientation, and logistic planning. 2. Five 60-minute group sessions with 6-10 stroke survivors (and their care partners as applicable) held approximately 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 week after enrollment. Sessions are co-lead by a nurse and a PED. 3. Six brief telephone sessions implemented after the conclusion of the 5 TEAM group sessions. Calls will be conducted every 2 weeks for 12 weeks. Calls will reinforce group session content, provide social support and facilitate linkage with other care providers.
Other
Waitlist 		Participants randomized to waitlist for 6 months, then offered the intervention for 6 months
  • Behavioral: TargEted MAnageMent Intervention (TEAM)
    TEAM targets acquisition of self-management expertise and use of healthy behaviors that are intended to reduce stroke risk and burden. TEAM participants will continue in their regular medical care, supplemented by the TEAM intervention. Components are as follows: 1. A 60 minute initial session in which the nurse and the PED meet with the patient who has experienced stroke or TIA. The initial session will cover introductions, orientation, and logistic planning. 2. Five 60-minute group sessions with 6-10 stroke survivors (and their care partners as applicable) held approximately 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 week after enrollment. Sessions are co-lead by a nurse and a PED. 3. Six brief telephone sessions implemented after the conclusion of the 5 TEAM group sessions. Calls will be conducted every 2 weeks for 12 weeks. Calls will reinforce group session content, provide social support and facilitate linkage with other care providers.

More Details

Status
Active, not recruiting
Sponsor
Case Western Reserve University

Study Contact

Detailed Description

The project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years. TEAM features a nurse-led, person-centered, holistic intervention that takes advantage of existing strengths in AA families/communities. TEAM uses peer educator dyads (PEDs) to provide support and model behaviors. The PED consists of an AA man peer educator (PE) with experience in managing his own stroke risk and a care partner. A care partner is someone who is the family member, friend or other individual of someone who has had a stroke or TIA. A care partner can be associated with a PE but they do not have to be. PEs and care partners will be matched depending on schedules and availability and may not always be members of the same household. The nurse and PED co-deliver TEAM to an AA male patient who has experienced stroke or TIA. Patients are also encouraged to include a family, friend, or other individual important his stroke recovery in the TEAM programming. The intervention is a practical approach suitable for implementation in specialty, primary care or community settings, and has the potential to reverse the unacceptably high morbidity seen in AA men due to stroke-related disorders.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.